Ongentys (Opicapone): A New COMT Inhibitor for the Treatment of Parkinson's Disease.

CONCLUSION: Opicapone is a safe and effective COMT inhibitor shown to reduce off episodes in patients with PD.
PMID: 33233916 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - November 24, 2020 Category: Drugs & Pharmacology Authors: St Onge E, Vanderhoof M, Miller S Tags: Ann Pharmacother Source Type: research